The Resistance Mechanism of Trastuzumab Deruxtexan in HER2 Positive Breast Cancer Patients.
This study is the spatial transcriptomic approach for revealing the resistance mechanism of trastuzumab deruxtexan in HER2 positive breast cancer patients.
HER2-positive Breast Cancer
DIAGNOSTIC_TEST: GeoMx data analysis with clinical outcome
Spatial transcriptomic analysis, Protein expression and relationship protein-protein in HER2 positive breast cancer tumor cells and tumor microenvironment., Before chemotherapy, curative surgery
This study is the spatial transcriptomic approach for revealing the resistance mechanism of trastuzumab deruxtexan in HER2 positive breast cancer patients.